122 related articles for article (PubMed ID: 30865104)
21. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
22. Effect of epidural analgesia on long-term outcomes after curative surgery for pancreatic cancer: A single-center cohort study in Taiwan.
Lin KJ; Hsu FK; Shyr YM; Ni YW; Tsou MY; Chang KY
J Chin Med Assoc; 2022 Jan; 85(1):124-128. PubMed ID: 35006128
[TBL] [Abstract][Full Text] [Related]
23. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
[TBL] [Abstract][Full Text] [Related]
25. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis.
Su CW; Lei HJ; Chau GY; Hung HH; Wu JC; Hsia CY; Lui WY; Su YH; Wu CW; Lee SD
Arch Surg; 2012 Feb; 147(2):137-44. PubMed ID: 22006855
[TBL] [Abstract][Full Text] [Related]
26. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
27. Longer duration of the Pringle maneuver is associated with hepatocellular carcinoma recurrence following curative resection.
Liu S; Li X; Li H; Guo L; Zhang B; Gong Z; Zhang J; Ye Q
J Surg Oncol; 2016 Jul; 114(1):112-8. PubMed ID: 27122256
[TBL] [Abstract][Full Text] [Related]
28. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
[TBL] [Abstract][Full Text] [Related]
29. Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
He W; Li B; Zheng Y; Zou R; Shen J; Cheng D; Tao Q; Liu W; Li Q; Chen G; Yuan Y
Liver Int; 2016 Nov; 36(11):1677-1687. PubMed ID: 27187721
[TBL] [Abstract][Full Text] [Related]
30. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.
Kim GA; Shim JH; Kim MJ; Kim SY; Won HJ; Shin YM; Kim PN; Kim KH; Lee SG; Lee HC
Br J Surg; 2016 Jan; 103(1):126-35. PubMed ID: 26572697
[TBL] [Abstract][Full Text] [Related]
33. Anatomical versus non-anatomical resection for hepatocellular carcinoma.
Marubashi S; Gotoh K; Akita H; Takahashi H; Ito Y; Yano M; Ishikawa O; Sakon M
Br J Surg; 2015 Jun; 102(7):776-84. PubMed ID: 25847111
[TBL] [Abstract][Full Text] [Related]
34. Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma.
Shindoh J; Makuuchi M; Matsuyama Y; Mise Y; Arita J; Sakamoto Y; Hasegawa K; Kokudo N
J Hepatol; 2016 Mar; 64(3):594-600. PubMed ID: 26505120
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
[TBL] [Abstract][Full Text] [Related]
36. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
[TBL] [Abstract][Full Text] [Related]
37. The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population.
Lacassie HJ; Cartagena J; Brañes J; Assel M; Echevarría GC
Anesth Analg; 2013 Sep; 117(3):653-660. PubMed ID: 23868889
[TBL] [Abstract][Full Text] [Related]
38. Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy.
Wu SJ; Zhang ZZ; Cheng NS; Xiong XZ; Yang L
Surg Oncol; 2019 Jun; 29():159-167. PubMed ID: 31196483
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study.
Liu K; Chen Y; Wu X; Huang Z; Lin Z; Jiang J; Tan W; Zhang L
Surg Endosc; 2017 Nov; 31(11):4790-4798. PubMed ID: 28389803
[TBL] [Abstract][Full Text] [Related]
40. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
